1. Academic Validation
  2. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China

  • Int J Infect Dis. 2020 Feb;91:264-266. doi: 10.1016/j.ijid.2020.01.009.
David S Hui 1 Esam I Azhar 2 Tariq A Madani 3 Francine Ntoumi 4 Richard Kock 5 Osman Dar 6 Giuseppe Ippolito 7 Timothy D Mchugh 8 Ziad A Memish 9 Christian Drosten 10 Alimuddin Zumla 11 Eskild Petersen 12
Affiliations

Affiliations

  • 1 Department of Medicine & Therapeutics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong, China. Electronic address: [email protected].
  • 2 Special Infectious Agents Unit, King Fahd Medical Research Center and, Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia.
  • 3 Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • 4 Fondation Congolaise pour la Recherche Médicale, Brazzaville, Republic of Congo.
  • 5 The Royal Veterinary College, University of London, Hawkshead Lane, North Mymms, Hatfield, Hertfordshire, UK.
  • 6 Chatham House Centre on Global Health Security, Royal Institute of International Affairs, London, UK.
  • 7 Lazzaro Spallanzani, National Institute for Infectious Diseases - IRCCS, Rome, Italy.
  • 8 Center for Clinical Microbiology, Division of Infection and Immunity, University College London, United Kingdom.
  • 9 Research CentreKing Saud Medical City, Ministry of Health, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • 10 Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Germany; Berlin Institute of Health, Institute of Virology, Berlin, Germany; German Centre for Infection Research, associated partner Charité, Berlin, Germany.
  • 11 Center for Clinical Microbiology, Division of Infection and Immunity, University College London, and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, United Kingdom.
  • 12 Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman; Institute for Clinical Medicine, Faculty of Health Science, University of Aarhus, Aarhus, Denmark.
Figures